The immunophenotypic profile of hematological malignancies is usually consistent among different sites of involvement; this consistency allows reliable diagnosis from peripheral blood, bone marrow, or lymph node, especially in cases of acute leukemia. Although in a minority of lymphoma patients, two or more different populations with discordant immunophenotypes have been described, either at the same or distinct sites. Here, we report two Korean patients with acute leukemia where the results of immunophenotypic analysis of the bone marrow specimen were different from those of immunohistochemical studies of a biopsy sample of a cervical lymph node, particularly with respect to myeloperoxidase and CD3. The clinical significance of the immunophenotypic disparity found in the patients still remains unknown; however, discrepancies between the different anatomic sites that are simultaneously involved can occur in a subset of leukemia patients. Therefore, integration of all the relevant results, including those of the bone marrow studies, may be helpful for accurate diagnosis and selecting appropriate treatment modalities. (Korean J Lab Med 2009; 29:396-401 [4] .
In leukemia, the immunological profile is generally considered to be conserved, irrespective of the involved site [5] .
Therefore, in most cases the definitive diagnosis in acute leukemia is based mainly on the results of bone marrow studies. Here, we present two cases of acute leukemia, which are interesting because the expression of some antigens was observed in the lymph node but not in the bone marrow.
CASE REPORTS

Patient 1
A 36-yr-old male patient was admitted with palpable neck masses that had developed 10 days prior to admission. His previous medical history was unremarkable, and his family 
Histomorphology and immunohistochemistry
Wright-Giemsa-stained peripheral blood and bone marrow smears were prepared for morphologic analysis. In addition, the aspirate was also stained with periodic acid-Schiff (PAS), peroxidase, and alpha-naphthyl butyrate esterase (ANBE). The histology of the cervical lymph node and bone marrow biopsy was analyzed in hematoxylin-eosin (HE) stained sections. The immunohistochemical stains that were applied on the paraffin-embedded tissue sections included CD2, CD3, CD5, CD7, CD56, CD79a, CD99, CD117, Ki-67, TIA-1, terminal deoxynucleotidyl transferase (TdT), and myeloperoxidase (MPO) for the lymph node and CD3, CD20, CD79a, TdT, and MPO for the bone marrow (all the stains were obtained from Dako Cytomation, Glostrup, Denmark, except for those of CD3, which were from Novocastra, Newcastle, UK).
The cervical lymph node biopsy of patient 1 showed almost complete replacement by malignant cells, which were medi-um-sized with one or two prominent nucleoli (Fig. 1) . Immunohistochemical staining on the paraffin-embedded tissue sections demonstrated that the tumor cells were positive for polyclonal CD3, CD7, CD99, CD117, Ki-67, MPO, and TdT (Table 1) . The bone marrow studies showed normocellular marrow (cellularity 40%) for the patient' s age; however, most nucleated cells were leukemic blasts having rather abundant cytoplasm with granules, and exhibited up to 80.1% of all nucleated cells. The blasts were negative for PAS, ANBE, TdT, and polyclonal CD3 and stained positively for Sudan black B (SBB), MPO, and peroxidase.
The cervical lymph node biopsy of patient 2 showed effacement of nodal architecture by diffuse infiltration of tumor cells that were medium to large-sized with a high nuclear cytoplasmic ratio, dispersed nuclear chromatin, and prominent nucleoli (Fig. 2) . CD3, CD56, CD99, TIA-1, and MPO were expressed by the majority of cells and scattered TdT positivity was detected among the cells (Table 1 ). The bone marrow aspiration smear showed medium to large-sized +  +  CD5  --ND  +  CD7  +  +  ND  +  CD10  ND  -ND  +  CD13  ND  +  ND  +  CD14  ND  -ND  -CD15  ND  -ND  -CD19  ND  -ND  -CD20  ND  -ND  -CD33  ND  +  ND  -CD34  ND  +  ND  -CD56  -ND  +  ND  CD64  ND  -ND  -CD79a  -ND  ND  ND  CD117  +  +  ND 
Immunophenotyping by flow cytometry and cytogenetic analysis
The bone marrow aspirate was stained using two combi- In patient 1, there was lymphoid light scatter with dim to moderate CD45-expression, which showed a single blast population with distinct positivity for numerous myeloid markers. In brief, the blasts were positive for CD7, CD13, CD33, CD34, CD117, and MPO. They were negative for CD3
and TdT (Table 1 , Fig. 1 ). Cytogenetic analysis was performed using 24-hr unstimulated cultures with bone marrow specimen, and the karyotype was described according to the International System for Human Cytogenetics Nomenclature 2005. His karyotype was 46,XY,del(5)(q33) [5] /46,idem, del(6)(q21q23) [6] /46,XY [9] .
Flow cytometric immunophenotyping of patient 2 revealed a single blast population with distinct positivity for numerous myeloid and T-cell markers. The blasts were positive for CD5, CD7, CD10, cytoplasmic CD3, CD13, CD117, and nuclear TdT. They were negative for MPO (Table 1 , Fig. 2 ).
At diagnosis, the cytogenetic study showed normal 46XX female karyotype in all the 20 metaphases that were analyzed.
DISCUSSION
It is well known that patients with non-Hodgkin lymphoma (NHL) may have histologic discordance between the different anatomic sites involved [6] [7] [8] . Earlier studies demonstrated differential expression of integrins (i.e., LFA-1) in tissue-based and leukemic NHL [9, 10] . Differences in the expression of lymphocyte homing receptors have also been postulated as a mechanism for specific tissue localization A discrepancy was noted between the clinical manifestations and the findings of the bone marrow study in patient 2. The rapid clinical progression observed in patient 2 is a usual finding in acute leukemia. Further, she received an ALL-designed chemotherapy and achieved complete remission. However, the blast count in the bone marrow was less than 20% at initial diagnosis, which was insufficient to render the diagnosis of an acute leukemia. It is unclear whether the final diagnosis of patient 2 is the bone narrow involvement of malignant lymphoma or an atypical acute leukemia.
Taking into effect the clinical manifestations, the treatment outcome, and findings of the lymph node biopsy, the final diagnosis was mixed-phenotype acute leukemia, T/myeloid (not otherwise specified).
The clinical significance of the immunophenotypic disparity found in the patients still remains unknown; however, the discrepancies between different anatomic sites that are simultaneously involved can occur in a subset of leukemia patients. Therefore, it is important that a definitive diagnosis should be assigned only after careful integration of all relevant results, including those of bone marrow studies.
To the best of our knowledge, this is the first report identifying an acute leukemia case with a different immuno- 
